4,272 SPDR S&P Biotech ETF $XBI Shares Bought by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 16.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,932 shares of the exchange traded fund’s stock after buying an additional 4,272 shares during the period. Kestra Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $4,720,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Angeles Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth about $28,000. Signature Equity Partners LLC increased its stake in SPDR S&P Biotech ETF by 1,285.7% in the 3rd quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 180 shares during the period. Root Financial Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $31,000. Axiom Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $26,000. Finally, Morling Financial Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the second quarter worth $36,000.

SPDR S&P Biotech ETF Trading Down 3.3%

Shares of NYSEARCA:XBI opened at $151.20 on Friday. The firm has a market cap of $10.24 billion, a price-to-earnings ratio of 20.64 and a beta of 0.87. SPDR S&P Biotech ETF has a 1 year low of $111.11 and a 1 year high of $169.89. The business has a fifty day simple moving average of $154.54 and a 200 day simple moving average of $142.81.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Featured Articles

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.